1. Home
  3. News
  5. Outreach

Outreach


Our EPSRC research selected as case study

Outreach
14 May, 2021

Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]

Research Group receive Innovate UK ICURe SETsquared Award

Outreach
24 February, 2021

We are delighted to be currently taking part in the UKRI Innovate UK ICURe SETsquared Cohort 32 (32-08 / 520268133: £30,000). This programme is allowing us to market validate our peptide hydrogel technology in a variety of applications both within drug delivery and the wider commercial landscape. Our Research Associate Simon Porter is currently undertaking these […]

Group receive major funding from EPSRC to develop peptide-like hydrogels for combined HIV-contraceptive therapy

General
03 September, 2019

We are excited to announce support from the Engineering and Physical Sciences Research Council (EPSRC) to develop of peptide-like hydrogels for use as a long-acting injectable delivery platform for combined HIV-contraceptive drug delivery. Total support (£766,542) will allow further development of our peptide-mimetic platforms in a key healthcare area in collaboration with our co-investigators at […]

OUR RESEARCH IS FUNDED BY

Contact Us
  • +44 (0) 28 9097 2273
  • garry.laverty@qub.ac.uk
  • School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, Co. Antrim, N.Ireland. BT97BL
  • Get Directions
Quick Links
Laverty Lab